Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2020 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
The First Case of TEMPI Syndrome in Japan.
Shizuku T, Matsui K, Yagi S, Iwabuchi S. Shizuku T, et al. Intern Med. 2020 Jul 15;59(14):1741-1744. doi: 10.2169/internalmedicine.3547-19. Epub 2020 Apr 16. Intern Med. 2020. PMID: 32295999 Free PMC article.
TEMPI syndrome, a disease entity comprising telangiectasia, erythrocytosis with high erythropoietin, monoclonal gammopathy, perinephric fluid collection, and intrapulmonary shunting, was first described by Sykes et al. in 2011. ...In addition to ascites, he had tela …
TEMPI syndrome, a disease entity comprising telangiectasia, erythrocytosis with high erythropoietin, monoclonal gammopathy, pe …
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation.
Kawamura S, Tamaki M, Nakamura Y, Kawamura M, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Okada Y, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Kimura SI, Nakasone H, Kako S, Kanda Y. Kawamura S, et al. Acta Haematol. 2022;145(5):553-559. doi: 10.1159/000525056. Epub 2022 May 23. Acta Haematol. 2022. PMID: 35605591
TEMPI syndrome is a rare disease associated with plasma cell neoplasms. ...To the best of our knowledge, this is the first case of TEMPI syndrome that was successfully treated with pomalidomide. Pomalidomide may be suitable for patients who do not resp …
TEMPI syndrome is a rare disease associated with plasma cell neoplasms. ...To the best of our knowledge, this is the first cas …
Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.
Belizaire R, Sykes DB, Chen YB, Spitzer TR, Makar RS. Belizaire R, et al. Transfusion. 2015 Sep;55(9):2142-8. doi: 10.1111/trf.13125. Epub 2015 Apr 24. Transfusion. 2015. PMID: 25911963
Patients with TEMPI syndrome have responded to therapies used to treat plasma cell dyscrasias and may benefit from autologous HPC transplantation. ...There were no adverse reactions during or after infusion. CONCLUSIONS: HPC-A collection from a patient with TEMPI …
Patients with TEMPI syndrome have responded to therapies used to treat plasma cell dyscrasias and may benefit from autologous …
Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature.
Undar L, Atas U, Iltar U, Salim O, Yucel OK, Alpsoy E. Undar L, et al. Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):702-707. doi: 10.1016/j.clml.2022.04.018. Epub 2022 Apr 22. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35624059 Review.
TEMPI syndrome was first defined in 2011 and classified as a plasma cell neoplasm with associated paraneoplastic syndrome in 2016. ...Here, we also review the clinical features of TEMPI syndrome, differential diagnosis and available treatment op …
TEMPI syndrome was first defined in 2011 and classified as a plasma cell neoplasm with associated paraneoplastic syndrome in 2 …
Subcutaneous bortezomib for treatment of TEMPI syndrome.
Jasim S, Mahmud G, Bastani B, Fesler M. Jasim S, et al. Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):e221-3. doi: 10.1016/j.clml.2014.07.004. Epub 2014 Jul 15. Clin Lymphoma Myeloma Leuk. 2014. PMID: 25172534 No abstract available.